<--GAT-->
Clinical Topics

No Link Found Between H. Pylori Infection, Unexplained Anemia

by U.S. Medicine

May 21, 2018

SYRACUSE, NY — Despite limited evidence to support the practice, testing for Helicobacter pylori (Hp) infection is recommended for work-up of unexplained iron deficiency anemia (IDA).

A study published in the journal Gastroenterology Report sought to investigate the association between Hp infection and unexplained iron deficiency (ID) or IDA in the older adult population without significant upper gastrointestinal source of blood loss.1

“Peptic ulcer disease caused by Hp infection can lead to gastrointestinal blood loss and IDA,” wrote State University of New York (SUNY), Upstate Medical University-led researchers. “Whether Hp infection can lead to IDA in the absence of peptic ulcer disease is controversial. Most of the data supporting association of Hp infection and IDA come from clinical studies conducted in children and premenopausal women with a relatively high iron requirement and in those living in areas with a high prevalence for Hp infection.

“The majority of the epidemiological studies that support this association have used serologic tests that do not necessarily diagnose active Hp infection,” they added. “In addition, most of these studies have not ruled out the major causes of IDA, such as peptic ulcer disease by esophagogastroduodenoscopy (EGD). Thus, the applicability of the available study findings in adult population living in areas with low prevalence for Hp infection who are not vulnerable to ID is controversial. The available data supporting association between Hp infection and ID do not prove cause and effect.”

To clarify the connection, the study team conducted research involving collection of Hp infection data on 1,253 consecutive patients undergoing diagnostic or therapeutic upper gastrointestinal endoscopy at the Syracuse, NY, VAMC from Jan. 1, 1998, to April 28, 2004. They compared the Hp-positive and Hp-negative groups to identify significant risk factors associated with ID and IDA.

Researchers noted that 523 of them had no significant upper and/or lower gastrointestinal source for blood loss or risk factors for IDA.

Overall, 103 of the patients (19.7%) had Hp infection, and 420 (80.3%) were found to be negative for Hp. In addition, 68 (22.1%) out of 307 subjects with available serum iron profile had unexplained ID, and 28 (5.4%) out of 510 subjects with available hemoglobin profile had unexplained IDA. No association was found between ID/IDA and Hp infection in univariate and multiple logistic regression analyses, the researchers pointed out.

“We found no association between unexplained ID or IDA and Hp infection in older adult population without peptic ulcer disease or significant upper gastrointestinal source of blood loss,” the study authors concluded.


1Savio John, Juan Diego Baltodano, Nilesh Mehta, Katherine Mark, Uma Murthy; Unexplained iron deficiency anemia: does Helicobacter pylori have a role to play?, Gastroenterology Report, published 08 February 2018. https://doi.org/10.1093/gastro/goy001

Related Articles

RA Fracture Risk Affected by Glucocorticoid Treatment

How much does systemic glucocorticoid exposure increase fracture among patients with newly-diagnosed inflammatory and immune-modulated conditions, including rheumatoid arthritis.

Obesity, Weight-Loss Both Worsen RA U.S. Medicine

Obese patients with rheumatoid arthritis report greater disability in cross-sectional studies, but what that means over the long term has not been studied often.


U.S. Medicine Recommends


More From oncology

Oncology

VA/National Cancer Institute Partnership Increases Veteran Access to Trials

Thanks to a new partnership between the National Cancer Institute and the VA, veterans with cancer will now have greater access to potentially lifesaving clinical trials.

Oncology

VA Continues Hepatocellular Screening, but Study Questions the Value

Although a recent study determined that screening veterans with cirrhosis for hepatocellular carcinoma did not reduce the risk of death associated with liver cancer, the VA has no plans to change its screening practices.

Oncology

Testosterone Therapy Not Linked to Aggressive Prostate Cancer in Veterans

Clinicians prescribing supplemental testosterone in men with low levels always have a nagging concern about the possible link between increasing hormone levels and prostate cancer.

Oncology

Side-effects Differ Between Radiation Therapies for Prostate Cancer

A recent study compared patient-reported disease-specific functional outcomes after external beam radiation therapy (EBRT) and EBRT combined with low-dose-rate brachytherapy prostate boost (EB-LDR) among men with localized prostate cancer.

Oncology

Parkinson's Drug Not Associated With Higher Prostate Cancer Risk

An increased incidence of prostate cancer was observed in Parkinson's disease (PD) patients treated with entacapone during a pre-approval randomized clinical trial, according to a new study which noted that the relationship had not yet been intensely investigated.

Facebook Comment

Subscribe to U.S. Medicine Print Magazine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and U.S. Public Health Service.

Subscribe Now

Receive Our Email Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

Sign Up